In a large analysis of more than 6,800 colorectal cancer patients across the University of California health system, those taking GLP-1 medications were less than half as likely to die within five years as patients who were not taking the drugs
Wortelboer, K., et al
Discussion Author Contributions Conceptualization, Writing-Original Draft, Writing-Reviewing and Editing: ML, Writing-Reviewing: JKC
Bridge (July 1, 2026-December 31, 2027): Medicare Part D enrollees can access GLP-1 medications for weight loss or weight maintenance for $50 per fill
It is that the urgency around eating diminishes
Of the 112 patients who were evaluable for efficacy, 27.7% of those treated with Trodelvy responded to treatment, with 5.4% experiencing a complete response and 22.3% experiencing a partial response